The authors wish to acknowledge funding from the European Regional Development Fund &#8211; FNUSA-ICRC (no. CZ.1.05/ 1.1.00/ 02.0123), the American Heart Association Scientist Development Grant (AHA #06-35185N), and the National Institutes of Health (NIH #T32HL007111).

1. Synthesis of Magnetite Gel
<ol>
	<li>Wash all glassware by using concentrated hydrochloric acid followed by deionized water followed by ethyl alcohol. Allow to dry O/N, preferably in a drying oven. 
	CAUTION! hydrochloric acid is harmful &#8211; wear personal protective equipment and work in a fume hood; ethyl alcohol is harmful &#8211; wear personal protective equipment.</li>
	<li>Use a Dreschel bottle to de-gas 500 ml of deionized H2O by gently bubbling N2 gas for 30 mins.</li>
	<li>Set-up the magnetite synthesis apparatus within a chemical fume hood.
	<ol>
		<li>Place a 500 ml three-neck round-bottom flask within an isomantle heater&#160;and secure the center neck using a clamp and stand.</li>
		<li>Install a rubber septum into one of the round-bottom flask&#8217;s side necks and a reflux condenser with a rubber septum into the remaining side neck. Continuously run cold water through the reflux condenser.</li>
		<li>Puncture the round-bottom flask&#8217;s rubber septum with a needle connected to an N2 gas line and puncture the reflux condenser&#8217;s rubber septum with a needle connected to a gas line running to a bubbler (i.e., flask with water) to visualize gas outflow.</li>
		<li>Install a blade paddle into the round-bottom flask&#8217;s center neck via a paddle adapter. Attach the blade paddle&#8217;s shaft to an overhead stirrer mounted onto a stand.</li>
	</ol>
	</li>
	<li>Purge the round-bottom flask with N2 gas and leave N2 gas flowing at a low but detectable rate.</li>
	<li>Remove the reflux condenser from the round-bottom flask and add 1.000 g of iron(III) chloride, 0.6125 g of iron(II) chloride tetrahydrate, and 50 ml of de-gassed H2O. 
	CAUTION! iron(III) chloride and iron(II) chloride tetrahydrate&#160;are harmful &#8211; wear personal protective equipment.</li>
	<li>Replace the reflux condenser and stir at 1,000 rpm while heating to 50 &#176;C. Stirring under these conditions produces 10 nm diameter magnetite nanoparticles.</li>
	<li>Once at 50 &#176;C, add 10 ml of 28% ammonium hydroxide solution by injecting through the rubber septum in the round-bottom flask while still stirring. 
	CAUTION! ammonium hydroxide is harmful &#8211; wear personal protective equipment. 
	NOTE: The ammonium hydroxide solution is used to precipitate the magnetite and the solution should turn black.</li>
	<li>Remove the rubber septum and N2 gas line from the round-bottom flask and heat to 90 &#176;C to boil off the ammonia gas while still stirring. 
	NOTE: It is optional to maintain the flow of N2 into the round-bottom flask by puncturing the reflux condenser&#8217;s rubber septum, however, oxidation of magnetite to maghemite is negligible during this step.</li>
	<li>Once at 90 &#176;C, add 1 ml of oleic acid to the round-bottom flask while still stirring. The oleic acid is used to coat the magnetite nanoparticles to form magnetite gel. 
	CAUTION! oleic acid is harmful &#8211; wear personal protective equipment.</li>
	<li>Replace the rubber septum and N2 gas line onto the round-bottom flask and remove the reflux condenser.</li>
	<li>Turn off heat and stir at 500 rpm for 2 hr.</li>
	<li>Remove the round-bottom flask from the isomantle heater and decant any remaining liquid while using a strong magnet held against the bottom of the flask to retain the magnetite gel. 
	CAUTION! handle the strong magnet with extreme care to avoid damage or injury.</li>
	<li>Allow magnetite gel to air-dry O/N (optional).</li>
</ol>
2. Purification of Magnetite Gel
<ol>
	<li>Add 40 ml of hexane into the round-bottom flask to dissolve the magnetite gel 
	CAUTION! hexane is harmful &#8211; wear personal protective equipment and work in a fume hood.</li>
	<li>Use a separatory funnel with 40 ml of de-gassed H2O to remove residual H2O from the magnetite solution.
	<ol>
		<li>Slowly pour the magnetite solution onto the H2O within the separatory funnel and gently swirl the two-phase liquid for 5 mins.</li>
		<li>Drain out and discard the lower aqueous fraction.</li>
		<li>Slowly add 40 ml of de-gassed H2O to the separatory funnel such that it settles beneath the magnetite solution and gently swirl and drain as before.</li>
		<li>Repeat to wash for a third time.</li>
	</ol>
	</li>
	<li>Transfer magnetite solution to an Erlenmeyer flask, add a few spatulas worth of anhydrous sodium sulfate, and swirl to remove any remaining residual H2O from the magnetite solution.</li>
	<li>Filter the magnetite solution through 1 &#181;m filter paper in a filter funnel to remove the sodium sulfate and residual H2O. 
	NOTE: Vacuum assistance is recommended.</li>
	<li>Transfer the magnetite solution to a 50 ml&#160;evaporating&#160;flask and use a rotary evaporator to evaporate the hexane for 2 h with the following conditions: moderate rotation speed, vacuum applied, evaporating&#160;flask in a 50 &#176;C water bath, and 24 &#176;C water circulating through the condenser. 
	NOTE: Optionally, store the magnetite gel prior to coating&#160;with PLGA.</li>
</ol>
3. Coating of Magnetite Nanoparticles with PLGA Shell
<ol>
	<li>Dissolve 3.60 g of PLGA (75/25 blend) in 240 ml of ethyl acetate to create a 1.5% (m/v) solution. CAUTION: ethyl acetate is harmful &#8211; wear personal protective equipment and work in a fume hood.</li>
	<li>Dissolve 25.00 g of Pluronic F-127 in 500 ml of de-gassed H2O using a magnetic stirrer to create a 5.0% (m/v) solution. 
	NOTE: Pluronic F-127 is a non-ionic amphiphilic block copolymer that acts as a biocompatible surfactant. It helps to stabilize the oil-in-water emulsion in step 3.3.2.</li>
	<li>Using a microspatula, collect the magnetite gel into six 0.040 g aliquots within weighted glass vials. Perform the following coating and washing process for each aliquot. 
	NOTE: The aliquots are necessary to ensure efficient handling and magnetic decantation, which will maximize purity and yield while minimizing degradation prior to freeze-drying in step 4.
	<ol>
		<li>Add a 0.040 g aliquot of magnetite gel and 40 ml of the PLGA solution to a plastic beaker and sonicate in an ultrasonic cleaner for 10 mins.</li>
		<li>Add 80 ml of the Pluronic solution to the plastic beaker and immediately emulsify with a laboratory mixer at the highest setting for 7 mins to form the PLGA coating on the magnetite nanoparticles as an oil-in-water emulsion.</li>
		<li>Immediately dilute the SPION solution in 1 L of deionized H2O and sonicate for 1 h in a chemical fume hood to evaporate the ethyl acetate.</li>
		<li>Place a strong magnet next to the SPION solution and gently stir to collect brownish SPIONs at the magnet. 
		NOTE: It may be necessary to intermittently stir for several hours before the solution turns whitish indicating that most of the SPIONs have been collected.</li>
		<li>Decant the aqueous solution while retaining the SPIONs in the beaker with the magnet.</li>
		<li>Wash the SPIONs three times as follows.
		<ol>
			<li>Suspend the SPIONs in 1 L of deionized H2O.</li>
			<li>Sonicate the SPION solution for 20 mins.</li>
			<li>Place a strong magnet next to the SPION solution and gently stir to collect brownish SPIONs at the magnet. It may be necessary to intermittently stir for several hours before the solution turns clear indicating that most of the SPIONs have been collected.</li>
			<li>Decant the aqueous solution while retaining the SPIONs in the beaker with the magnet.</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Collect the SPIONs synthesized from each of the six magnetite gel aliquots into a single weighted glass vial as an aqueous suspension. Optionally decant excess water magnetically as needed.</li>
</ol>
4. Freeze-drying of SPIONs
<ol>
	<li>Freeze the SPION solution.</li>
	<li>Freeze-dry the SPION solution O/N in a lyophilizer.</li>
	<li>Weigh the freeze-dried SPIONs. Freeze-dried SPIONs can be stored at -20 &#176;C until used for cell labeling. 
	NOTE: Storage at -20 &#176;C dramatically reduces degradation kinetics and increases shelf life.</li>
</ol>
5. Labeling of Cells with SPIONs
<ol>
	<li>Suspend an aliquot of SPIONs in phosphate-buffered saline (PBS) at a concentration of 40 mg/ml and sonicate for 30 mins.</li>
	<li>Add the SPION solution to a nearly confluent flask of cells at a concentration of 5 &#181;l/ml of cell culture medium. Ensure even distribution by gently rocking the flask.</li>
	<li>Incubate the cells for 16 hr at 37 &#176;C.</li>
	<li>Gently aspirate culture medium and wash cells twice with PBS.</li>
	<li>Collect magnetically-labeled cells and use for experiments.</li>
	<li>Unused SPION solution can be stored at 4 &#176;C and should be used within a few months. Sonicate for 30 mins before each use.</li>
</ol>

<ol>
	<li>Burgess, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Targeted+delivery+of+neural+stem+cells+to+the+brain+using+MRI-guided+focused+ultrasound+to+disrupt+the+blood-brain+barrier.">Targeted delivery of neural stem cells to the brain using MRI-guided focused ultrasound to disrupt the blood-brain barrier.</a> PLoS One. 6 (11), e27877 (2011).</li><li>Nguyen, K. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mesenchymal+Stem+Cells+as+Targeted+Cell+Vehicles+to+Deliver+Drug-loaded+Nanoparticles+for+Cancer+Therapy.">Mesenchymal Stem Cells as Targeted Cell Vehicles to Deliver Drug-loaded Nanoparticles for Cancer Therapy.</a> J Nanomed Nanotechol. 4 (1), e128 (2013).</li><li>Kean, T. J., Lin, P., Caplan, A. I., Dennis, J. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=MSCs:+Delivery+Routes+and+Engraftment,+Cell-Targeting+Strategies,+and+Immune+Modulation.">MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation.</a> Stem Cells Int. , 732742 (2013).</li><li>Suzuki, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Targeted+cell+delivery+into+infarcted+rat+hearts+by+retrograde+intracoronary+infusion:+distribution,+dynamics,+and+influence+on+cardiac+function.">Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: distribution, dynamics, and influence on cardiac function.</a> Circulation. 110 (11 Suppl 1), II225-II230 (2004).</li><li>Garbern, J. C., Lee, R. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cardiac+stem+cell+therapy+and+the+promise+of+heart+regeneration.">Cardiac stem cell therapy and the promise of heart regeneration.</a> Cell Stem Cell. 12 (6), 689-698 (2013).</li><li>Duckers, H. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Accelerated+vascular+repair+following+percutaneous+coronary+intervention+by+capture+of+endothelial+progenitor+cells+promotes+regression+of+neointimal+growth+at+long+term+follow-up:+final+results+of+the+Healing+II+trial+using+an+endothelial+progenitor+cell+capturing+stent+(Genous+R+stent).">Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent).</a> EuroIntervention. 3 (3), 350-358 (2007).</li><li>Pan, Y., Du, X., Zhao, F., Xu, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Magnetic+nanoparticles+for+the+manipulation+of+proteins+and+cells.">Magnetic nanoparticles for the manipulation of proteins and cells.</a> Chem Soc Rev. 41 (7), 2912-2942 (2012).</li><li>Huang, Z. Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Deep+magnetic+capture+of+magnetically+loaded+cells+for+spatially+targeted+therapeutics.">Deep magnetic capture of magnetically loaded cells for spatially targeted therapeutics.</a> Biomaterials. 31 (8), 2130-2140 (2010).</li><li>Shen, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Comparison+of+Magnetic+Intensities+for+Mesenchymal+Stem+Cell+Targeting+Therapy+on+Ischemic+Myocardial+Repair:+High+Magnetic+Intensity+Improves+Cell+Retention+but+Has+No+Additional+Functional+Benefit.">Comparison of Magnetic Intensities for Mesenchymal Stem Cell Targeting Therapy on Ischemic Myocardial Repair: High Magnetic Intensity Improves Cell Retention but Has No Additional Functional Benefit.</a> Cell Transplant. , (2014).</li><li>Cheng, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Magnetic+antibody-linked+nanomatchmakers+for+therapeutic+cell+targeting.">Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting.</a> Nat Commun. 5, 4880 (2014).</li><li>Vandergriff, A. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Magnetic+targeting+of+cardiosphere-derived+stem+cells+with+ferumoxytol+nanoparticles+for+treating+rats+with+myocardial+infarction.">Magnetic targeting of cardiosphere-derived stem cells with ferumoxytol nanoparticles for treating rats with myocardial infarction.</a> Biomaterials. 35 (30), 8528-8539 (2014).</li><li>Huang, Z., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Magnetic+targeting+enhances+retrograde+cell+retention+in+a+rat+model+of+myocardial+infarction.">Magnetic targeting enhances retrograde cell retention in a rat model of myocardial infarction.</a> Stem Cell Res Ther. 4 (6), 149 (2013).</li><li>Chaudeurge, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Can+magnetic+targeting+of+magnetically+labeled+circulating+cells+optimize+intramyocardial+cell+retention.">Can magnetic targeting of magnetically labeled circulating cells optimize intramyocardial cell retention.</a> Cell Transplant. 21 (4), 679-691 (2012).</li><li>Cheng, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Magnetic+targeting+enhances+engraftment+and+functional+benefit+of+iron-labeled+cardiosphere-derived+cells+in+myocardial+infarction.">Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction.</a> Circ Res. 106 (10), 1570-1581 (2010).</li><li>Yanai, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Focused+magnetic+stem+cell+targeting+to+the+retina+using+superparamagnetic+iron+oxide+nanoparticles.">Focused magnetic stem cell targeting to the retina using superparamagnetic iron oxide nanoparticles.</a> Cell Transplant. 21 (6), 1137-1148 (2012).</li><li>Ordidge, K. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Coupled+cellular+therapy+and+magnetic+targeting+for+airway+regeneration.">Coupled cellular therapy and magnetic targeting for airway regeneration.</a> Biochem Soc Trans. 42 (3), 657-661 (2014).</li><li>El Haj, A. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=An+in+vitro+model+of+mesenchymal+stem+cell+targeting+using+magnetic+particle+labelling.">An in vitro model of mesenchymal stem cell targeting using magnetic particle labelling.</a> J Tissue Eng Regen Med. , (2012).</li><li>Vanecek, V., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Highly+efficient+magnetic+targeting+of+mesenchymal+stem+cells+in+spinal+cord+injury.">Highly efficient magnetic targeting of mesenchymal stem cells in spinal cord injury.</a> Int J Nanomedicine. 7, 3719-3730 (2012).</li><li>Sasaki, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Therapeutic+effects+with+magnetic+targeting+of+bone+marrow+stromal+cells+in+a+rat+spinal+cord+injury+model.">Therapeutic effects with magnetic targeting of bone marrow stromal cells in a rat spinal cord injury model.</a> Spine (Phila Pa 1976). 36 (12), 933-938 (2011).</li><li>Oshima, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Enhancement+of+bone+formation+in+an+experimental+bony+defect+using+ferumoxide-labelled+mesenchymal+stromal+cells+and+a+magnetic+targeting+system.">Enhancement of bone formation in an experimental bony defect using ferumoxide-labelled mesenchymal stromal cells and a magnetic targeting system.</a> J Bone Joint Surg Br. 92 (11), 1606-1613 (2010).</li><li>Luciani, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Magnetic+targeting+of+iron-oxide-labeled+fluorescent+hepatoma+cells+to+the+liver.">Magnetic targeting of iron-oxide-labeled fluorescent hepatoma cells to the liver.</a> Eur Radiol. 19 (5), 1087-1096 (2009).</li><li>Oshima, S., Kamei, N., Nakasa, T., Yasunaga, Y., Ochi, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Enhancement+of+muscle+repair+using+human+mesenchymal+stem+cells+with+a+magnetic+targeting+system+in+a+subchronic+muscle+injury+model.">Enhancement of muscle repair using human mesenchymal stem cells with a magnetic targeting system in a subchronic muscle injury model.</a> J Orthop Sci. 19 (3), 478-488 (2014).</li><li>Ohkawa, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Magnetic+targeting+of+human+peripheral+blood+CD133++cells+for+skeletal+muscle+regeneration.">Magnetic targeting of human peripheral blood CD133+ cells for skeletal muscle regeneration.</a> Tissue Eng Part C Methods. 19 (8), 631-641 (2013).</li><li>Tefft, B. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Magnetizable+Duplex+Steel+Stents+Enable+Endothelial+Cell+Capture.">Magnetizable Duplex Steel Stents Enable Endothelial Cell Capture.</a> Ieee T Magn. 49 (1), 463-466 (2013).</li><li>Uthamaraj, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Design+and+validation+of+a+novel+ferromagnetic+bare+metal+stent+capable+of+capturing+and+retaining+endothelial+cells.">Design and validation of a novel ferromagnetic bare metal stent capable of capturing and retaining endothelial cells.</a> ABME. 42 (12), 2416-2424 (2014).</li><li>Polyak, B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=High+field+gradient+targeting+of+magnetic+nanoparticle-loaded+endothelial+cells+to+the+surfaces+of+steel+stents.">High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents.</a> Proc Natl Acad Sci U.S.A. 105 (2), 698-703 (2008).</li><li>Pislaru, S. V., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Magnetically+targeted+endothelial+cell+localization+in+stented+vessels.">Magnetically targeted endothelial cell localization in stented vessels.</a> J Am Coll Cardiol. 48 (9), 1839-1845 (2006).</li><li>Pislaru, S. V., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Magnetic+forces+enable+rapid+endothelialization+of+synthetic+vascular+grafts.">Magnetic forces enable rapid endothelialization of synthetic vascular grafts.</a> Circulation. 114 (1 Suppl), 314-318 (2006).</li><li>Wang, Y. X., Xuan, S., Port, M., Idee, J. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Recent+advances+in+superparamagnetic+iron+oxide+nanoparticles+for+cellular+imaging+and+targeted+therapy+research.">Recent advances in superparamagnetic iron oxide nanoparticles for cellular imaging and targeted therapy research.</a> Curr Pharm Des. 19 (37), 6575-6593 (2013).</li><li>Yellen, B. B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Targeted+drug+delivery+to+magnetic+implants+for+therapeutic+applications.">Targeted drug delivery to magnetic implants for therapeutic applications.</a> J Magn Magn Mater. 293 (1), 647-654 (2005).</li><li>Granot, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Clinically+viable+magnetic+poly(lactide-co-glycolide)+particles+for+MRI-based+cell+tracking.">Clinically viable magnetic poly(lactide-co-glycolide) particles for MRI-based cell tracking.</a> Magn Reson Med. , (2013).</li><li>Levy, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Long+term+in+vivo+biotransformation+of+iron+oxide+nanoparticles.">Long term in vivo biotransformation of iron oxide nanoparticles.</a> Biomaterials. 32 (16), 3988-3999 (2011).</li><li>Mirshafiee, V., Mahmoudi, M., Lou, K., Cheng, J., Kraft, M. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Protein+corona+significantly+reduces+active+targeting+yield.">Protein corona significantly reduces active targeting yield.</a> Chem Commun (Camb). 49 (25), 2557-2559 (2013).</li><li>Salvati, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Transferrin-functionalized+nanoparticles+lose+their+targeting+capabilities+when+a+biomolecule+corona+adsorbs+on+the+surface.">Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.</a> Nat Nanotechnol. 8 (2), 137-143 (2013).</li><li>Landazuri, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Magnetic+targeting+of+human+mesenchymal+stem+cells+with+internalized+superparamagnetic+iron+oxide+nanoparticles.">Magnetic targeting of human mesenchymal stem cells with internalized superparamagnetic iron oxide nanoparticles.</a> Small. 9 (23), 4017-4026 (2013).</li><li>Sun, J. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=In+vitro+labeling+of+endothelial+progenitor+cells+isolated+from+peripheral+blood+with+superparamagnetic+iron+oxide+nanoparticles.">In vitro labeling of endothelial progenitor cells isolated from peripheral blood with superparamagnetic iron oxide nanoparticles.</a> Mol Med Rep. 6 (2), 282-286 (2012).</li><li>Zhang, B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Detection+of+viability+of+transplanted+beta+cells+labeled+with+a+novel+contrast+agent+-+polyvinylpyrrolidone-coated+superparamagnetic+iron+oxide+nanoparticles+by+magnetic+resonance+imaging.">Detection of viability of transplanted beta cells labeled with a novel contrast agent - polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles by magnetic resonance imaging.</a> Contrast Media Mol Imaging. 7 (1), 35-44 (2012).</li><li>Song, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Labeling+efficacy+of+superparamagnetic+iron+oxide+nanoparticles+to+human+neural+stem+cells:+comparison+of+ferumoxides,+monocrystalline+iron+oxide,+cross-linked+iron+oxide+(CLIO)-NH2+and+tat-CLIO.">Labeling efficacy of superparamagnetic iron oxide nanoparticles to human neural stem cells: comparison of ferumoxides, monocrystalline iron oxide, cross-linked iron oxide (CLIO)-NH2 and tat-CLIO.</a> Korean J Radiol. 8 (5), 365-371 (2007).</li></ol>

The authors declare that they have no competing financial interests.

As with any nanoparticle synthesis protocol, the purity of the reactant chemicals is critical for achieving high quality SPIONs that will have minimal cytotoxic effects. It is therefore important to purchase very pure reagents including oleic acid (&#8805;99%), iron(II) chloride tetrahydrate (&#8805;99.99%), iron(III) chloride (&#8805;99.99%), ethyl acetate (HPLC grade, &#8805;99.9%), hexane (HPLC grade, &#8805;97.0%), ammonium hydroxide (&#8805;99.99%), and sodium sulfate (&#8805;99.0%). It is of particular importance t...

Targeted delivery and capture of cells to specific sites within the body is desirable for a variety of biomedical applications. Delivery of neural stem cells to the brain by MRI-guided focused ultrasound has been proposed as a possible treatment option for neurodegenerative disease, traumatic brain injury, and stroke1. Mesenchymal stem cells are being studied for their ability to deliver anti-cancer drugs to tumors due to their natural tumor-tropic properties2,3. Cardiac stem cells have been delivered to the heart as a possible treatment for myocardial infarction4,5. Vascular stents have been developed with CD34 antibodies to capture circulating progenitor cells6. While promising, these cell targeting approaches present drawbacks including lack of cell specificity, inconsistent cell retention, and off-target cell delivery.
The overall goal of the current method is to enable magnetically directed targeting of cells for a variety of cell delivery and sorting applications. Magnetic targeting allows for controlled delivery of specific cells to a specific target site with minimal off-target effects7. The magnetic fields can be generated by implanted or external devices to safely direct the movement of magnetically-labeled cells within the body8. Numerous research efforts have focused on magnetically directed targeting of stem cells to injured tissues such as the heart9-14, retina15, lung16, skin17, spinal cord18,19, bone20, liver21, and muscle22,23 in order to improve regeneration outcomes.
Magnetic targeting of cells has also been studied extensively as a means to endothelialize implantable cardiovascular devices. A uniform and complete endothelium provides a barrier between the device and circulating blood elements to mitigate thrombosis and inflammation. Endothelial cells can be delivered to the device either prior to implantation or via the vascular system following implantation. In both cases, magnetic fields are used to capture cells to the surface of the device and retain the cells when subjected to the shear stress generated by circulating blood. Magnetic vascular stents24-27 and vascular grafts28 have both been fabricated and tested for this purpose.
Magnetic cell targeting requires a strategy for labeling cells with magnetic carrier particles. These particles can be bound to the surface of cells via antibodies or ligand/receptor pairs or they can be endocytosed into the cells. Superparamagnetic iron oxide nanoparticles (SPION) are biodegradable, biocompatible, and readily endocytosed by a variety of cell types29. These particles effectively render a cell responsive to magnetic fields and are naturally degraded over time. SPIONs provide a straightforward and safe means of magnetically labeling cells in culture for a variety of magnetic targeting and sorting applications. A method for synthesizing SPIONs with a magnetite (Fe3O4) core and poly(lactic-co-glycolic acid) (PLGA) shell is provided. In addition, a method for labeling cells in culture with SPIONs is provided.

<table border="0" cellpadding="0" cellspacing="0">
	<tbody>
		<tr>
			<td>Ammonium Hydroxide solution, 28% NH3 in H2O, &#8805;99.99% trace metal basis</td>
			<td>Sigma-Aldrich</td>
			<td>338818-100ML&#160;</td>
			<td>Harmful reagent - wear personal protective equipment</td>
		</tr>
		<tr>
			<td>Dreschel bottle, 500 mL</td>
			<td>Ace Glass</td>
			<td>5516-16</td>
			<td></td>
		</tr>
		<tr>
			<td>Ethyl Acetate, CHROMASOLVR Plus, for HPLC, 99.9%&#160;</td>
			<td>Sigma-Aldrich</td>
			<td>650528-1L</td>
			<td>Harmful reagent - wear personal protective equipment &#38; work in fume hood</td>
		</tr>
		<tr>
			<td>Ethyl alcohol</td>
			<td>Sigma-Aldrich</td>
			<td>E7023</td>
			<td>Harmful reagent - wear personal protective equipment</td>
		</tr>
		<tr>
			<td>Filter paper, 3 cm dia, grade 1</td>
			<td>Fisher</td>
			<td>09-805P</td>
			<td>For use with glass filter funnel</td>
		</tr>
		<tr>
			<td>Glass beakers, 1 L</td>
			<td>Fisher</td>
			<td>FB-101-1000</td>
			<td>For washing SPIONs</td>
		</tr>
		<tr>
			<td>Glass filter funnel, vacuum hose adapter, fits 24/40, 30 mL</td>
			<td>Fisher</td>
			<td>K954100-0344&#160;</td>
			<td></td>
		</tr>
		<tr>
			<td>Glass vial caps</td>
			<td>Fisher</td>
			<td>03-391-46</td>
			<td>For use with glass vials</td>
		</tr>
		<tr>
			<td>Glass vials, 2 mL</td>
			<td>Fisher</td>
			<td>03-391-44</td>
			<td>For collecting magnetite gel &#38; SPIONs</td>
		</tr>
		<tr>
			<td>Hexane, CHROMASOLVR, for HPLC, &#8805;97.0% (GC)</td>
			<td>Sigma-Aldrich</td>
			<td>34859-1L&#160;</td>
			<td>Harmful reagent - wear personal protective equipment &#38; work in fume hood</td>
		</tr>
		<tr>
			<td>Hydrochloric acid</td>
			<td>Sigma-Aldrich</td>
			<td>H1758</td>
			<td>Harmful reagent - wear personal protective equipment &#38; work in fume hood</td>
		</tr>
		<tr>
			<td>Iron(II) chloride tetrahydrate, &#8805;99.99% trace metals basis&#160;</td>
			<td>Sigma-Aldrich</td>
			<td>380024-5G</td>
			<td>Harmful reagent - wear personal protective equipment</td>
		</tr>
		<tr>
			<td>Iron(III) chloride anhydrous, powder, &#8805;99.99% trace metals basis</td>
			<td>Sigma-Aldrich</td>
			<td>451649-1G</td>
			<td>Harmful reagent - wear personal protective equipment</td>
		</tr>
		<tr>
			<td>Isomantle heater, 500 mL</td>
			<td>Voight Global</td>
			<td>EM0500/CEX1</td>
			<td></td>
		</tr>
		<tr>
			<td>Laboratory mixer</td>
			<td>Silverson</td>
			<td>L5M-A</td>
			<td></td>
		</tr>
		<tr>
			<td>Lyophilizer</td>
			<td>Labconco</td>
			<td>7670520</td>
			<td></td>
		</tr>
		<tr>
			<td>Microspatulas</td>
			<td>Fisher</td>
			<td>21-401-25A</td>
			<td>For transfering magnetite gel</td>
		</tr>
		<tr>
			<td>NdFeB magnet, 1 in x 1 in x 1 in</td>
			<td>Amazing Magnets</td>
			<td>C1000H-M</td>
			<td>Very strong magnet, handle with care</td>
		</tr>
		<tr>
			<td>Oleic acid, &#8805;99% (GC)</td>
			<td>Sigma-Aldrich</td>
			<td>O1008-5G&#160;</td>
			<td>Store in freezer; Harmful reagent - wear personal protective equipment</td>
		</tr>
		<tr>
			<td>Overhead stirrer</td>
			<td>IKA</td>
			<td>2572201</td>
			<td></td>
		</tr>
		<tr>
			<td>Overhead stirrer clamp</td>
			<td>IKA</td>
			<td>2664000</td>
			<td>For use with overhead stirrer</td>
		</tr>
		<tr>
			<td>Overhead stirrer H-stand</td>
			<td>IKA</td>
			<td>1412000</td>
			<td>For use with overhead stirrer</td>
		</tr>
		<tr>
			<td>Phosphate buffered saline</td>
			<td>Life Technologies</td>
			<td>10010-023</td>
			<td></td>
		</tr>
		<tr>
			<td>Plastic beakers, 250 mL</td>
			<td>Fisher</td>
			<td>02-591-28</td>
			<td></td>
		</tr>
		<tr>
			<td>PLGA PURASORB PDLG (75/25 blend)</td>
			<td>Purac</td>
			<td>PDLG 7502</td>
			<td>PDLG 7502A may be used as well; Store in freezer</td>
		</tr>
		<tr>
			<td>Pluronic F-127 powder, BioReagent, suitable for cell culture</td>
			<td>Sigma-Aldrich</td>
			<td>P2443-250G&#160;</td>
			<td></td>
		</tr>
		<tr>
			<td>PTFE expandable blade paddle, 8 mm dia</td>
			<td>SciQuip</td>
			<td>SP4018</td>
			<td></td>
		</tr>
		<tr>
			<td>PTFE vessel adapter, fits 24/40, 8 mm dia paddle</td>
			<td>Monmouth Scientific</td>
			<td>PTFE Vessel Adaptor A480</td>
			<td>For use with PTFE expandable blade paddle</td>
		</tr>
		<tr>
			<td>Recirculating chiller</td>
			<td>Clarkson</td>
			<td>696613</td>
			<td>For use with rotoevaporator</td>
		</tr>
		<tr>
			<td>Reflux condenser, fits 24/40, 250 mm</td>
			<td>Ace Glass</td>
			<td>5997-133</td>
			<td></td>
		</tr>
		<tr>
			<td>Rotoevaporator</td>
			<td>Clarkson</td>
			<td>216949</td>
			<td></td>
		</tr>
		<tr>
			<td>Round bottom flask, 50 mL, 24/40 joint</td>
			<td>Sigma-Aldrich</td>
			<td>Z414484</td>
			<td>For use with rotoevaporator</td>
		</tr>
		<tr>
			<td>Rubber septa, fits 24/40</td>
			<td>Ace Glass</td>
			<td>9096-56</td>
			<td></td>
		</tr>
		<tr>
			<td>Separatory funnel with stopper, 250 mL</td>
			<td>Fisher</td>
			<td>10-438E</td>
			<td></td>
		</tr>
		<tr>
			<td>Sodium sulfate ACS reagent, &#8805;99.0%, anhydrous, granular</td>
			<td>Sigma-Aldrich</td>
			<td>239313-500G&#160;</td>
			<td></td>
		</tr>
		<tr>
			<td>Three neck round bottom flask, angled, 24/40 joints, 500 mL</td>
			<td>Ace Glass</td>
			<td>6948-16</td>
			<td></td>
		</tr>
		<tr>
			<td>Ultrasonic cleaner perforated pan</td>
			<td>Fisher</td>
			<td>15-335-20A</td>
			<td>For use with ultrasonic cleaner</td>
		</tr>
		<tr>
			<td>Ultrasonic cleaner, 2.8 L</td>
			<td>Fisher</td>
			<td>15-335-20</td>
			<td></td>
		</tr>
		<tr>
			<td>Vacuum controller</td>
			<td>Clarkson</td>
			<td>216639</td>
			<td>For use with rotoevaporator (optional)</td>
		</tr>
		<tr>
			<td>Vacuum pump</td>
			<td>Clarkson</td>
			<td>219959</td>
			<td>For use with rotoevaporator</td>
		</tr>
	</tbody>
</table>

cell labeling and targeting with superparamagnetic iron oxide nanoparticles

Targeted delivery of cells and therapeutic agents would benefit a wide range of biomedical applications by concentrating the therapeutic effect at the target site while minimizing deleterious effects to off-target sites. Magnetic cell targeting is an efficient, safe, and straightforward delivery technique. Superparamagnetic iron oxide nanoparticles (SPION) are biodegradable, biocompatible, and can be endocytosed into cells to render them responsive to magnetic fields. The synthesis process involves creating magnetite (Fe3O4) nanoparticles followed by high-speed emulsification to form a poly(lactic-co-glycolic acid) (PLGA) coating. The PLGA-magnetite SPIONs are approximately 120 nm in diameter including the approximately 10 nm diameter magnetite core. When placed in culture medium, SPIONs are naturally endocytosed by cells and stored as small clusters within cytoplasmic endosomes. These particles impart sufficient magnetic mass to the cells to allow for targeting within magnetic fields. Numerous cell sorting and targeting applications are enabled by rendering various cell types responsive to magnetic fields. SPIONs have a variety of other biomedical applications as well including use as a medical imaging contrast agent, targeted drug or gene delivery, diagnostic assays, and generation of local hyperthermia for tumor therapy or tissue soldering.

Magnetite nanoparticles are approximately 10 nm in diameter as a result of stirring an aqueous solution of iron(III) chloride and iron(II) chloride tetrahydrate at 50 &#176;C and 1,000 rpm (Figure 1). These results demonstrate successful synthesis of magnetite nanoparticles. It is important to verify the size and shape of magnetite nanoparticles taken from a small sample of the batch when attempting the synthesis for the first time. Transmission electron microscopy (TEM) is the preferred method for visua...

Watch this Scientific Journal Video about Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles at JoVE.com

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Targeted cell delivery is useful in a variety of biomedical applications. The goal of this protocol is to use superparamagnetic iron oxide nanoparticles (SPION) to label cells and thereby enable magnetic cell targeting approaches for a high degree of control over cell delivery and localization.

Targeted delivery of cells and therapeutic agents would benefit a wide range of biomedical applications by concentrating the therapeutic effect at the ...

cell-labeling-targeting-with-superparamagnetic-iron-oxide

Research

JoVE Journal

Bioengineering

12.0K 조회수.  Mayo Clinic. Targeted cell delivery is useful in a variety of biomedical applications. The goal of this protocol is to use superparamagnetic iron oxide nanoparticles (SPION) to label cells and thereby enable magnetic cell targeting approaches for a high degree of control over cell delivery and localization.

비디오: Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Production and Targeting of Monovalent Quantum Dots

The multivalent nature of commercial quantum dots (QDs) and the difficulties associated with producing monovalent dots have limited their applications in biology, where clustering and the spatial organization of biomolecules is often the object of study. We describe here a protocol to produce monovalent quantum dots (mQDs) that can be accomplished in most biological research laboratories via a simple mixing of CdSe/ZnS core/shell QDs with phosphorothioate DNA (ptDNA) of defined length. After a single ptDNA strand has wrapped the QD, additional strands are excluded from the surface. Production of mQDs in this manner can be accomplished at small and large scale, with commercial reagents, and in minimal steps. These mQDs can be specifically directed to biological targets by hybridization to a complementary single stranded targeting DNA. We demonstrate the use of these mQDs as imaging probes by labeling SNAP-tagged Notch receptors on live mammalian cells, targeted by mQDs bearing a benzylguanine moiety.

We provide detailed instructions for the preparation of monovalent targeted quantum dots (mQDs) from phosphorothioate DNA of defined length. DNA wrapping occurs in high yield, and therefore, products do not require purification. We demonstrate the use of the SNAP tag to target mQDs to cell-surface receptors for live-cell imaging applications.

The multivalent nature of commercial quantum dots (QDs) and the difficulties associated with producing monovalent dots have limited their applications in ...

Fabrication of a Functionalized Magnetic Bacterial Nanocellulose with Iron Oxide Nanoparticles

In this study, bacterial nanocellulose (BNC) produced by the bacteria Gluconacetobacter xylinus is synthesized and impregnated in situ with iron oxide nanoparticles (IONP) (Fe3O4) to yield a magnetic bacterial nanocellulose (MBNC). The synthesis of MBNC is a precise and specifically designed multi-step process. Briefly, bacterial nanocellulose (BNC) pellicles are formed from preserved G. xylinus strain according to our experimental requirements of size and morphology. A solution of iron(III) chloride hexahydrate (FeCl3&#183;6H2O) and iron(II) chloride tetrahydrate (FeCl2&#183;4H2O) with a 2:1 molar ratio is prepared and diluted in deoxygenated high purity water. A BNC pellicle is then introduced in the vessel with the reactants. This mixture is stirred and heated at 80 &#176;C in a silicon oil bath and ammonium hydroxide (14%) is then added by dropping to precipitate the ferrous ions into the BNC mesh. This last step allows forming in situ magnetite nanoparticles (Fe3O4) inside the bacterial nanocellulose mesh to confer magnetic properties to BNC pellicle. A toxicological assay was used to evaluate the biocompatibility of the BNC-IONP pellicle. Polyethylene glycol (PEG) was used to cover the IONPs in order to improve their biocompatibility. Scanning electron microscopy (SEM) images showed that the IONP were located preferentially in the fibril interlacing spaces of the BNC matrix, but some of them were also found along the BNC ribbons. Magnetic force microscope measurements performed on the MBNC detected the presence magnetic domains with high and weak intensity magnetic field, confirming the magnetic nature of the MBNC pellicle. Young&#39;s modulus values obtained in this work are also in a reasonable agreement with those reported for several blood vessels in previous studies.

Here, we present a protocol to make a bacterial nanocellulose (BNC) magnetic for applications in damaged blood vessel reconstruction. The BNC was synthesized by G. xylinus strain. On the other hand, magnetization of the BNC was realized through in situ precipitation of Fe2+ and Fe3+ ferrous ions inside the BNC mesh.

In this study, bacterial nanocellulose (BNC) produced by the bacteria Gluconacetobacter xylinus is synthesized and impregnated in situ with iron oxide ...

Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications

Nanoparticle-based delivery vehicles have shown great promise for intracellular targeting applications, providing a mechanism to specifically alter cellular signaling and gene expression. In a previous investigation, the synthesis of ultra-small solid lipid nanoparticles (SLNs) for topical drug delivery and biomarker detection applications was demonstrated. SLNs are a well-studied example of a nanoparticle delivery system that has emerged as a promising drug delivery vehicle. In this study, SLNs were loaded with a fluorescent dye and used as a model to investigate particle-cell interactions. The phase inversion temperature (PIT) method was used for the synthesis of ultra-small populations of biocompatible nanoparticles. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylphenyltetrazolium bromide (MTT) assay was utilized in order to establish appropriate dosing levels prior to the nanoparticle-cell interaction studies. Furthermore, primary human dermal fibroblasts and mouse dendritic cells were exposed to dye-loaded SLN over time and the interactions with respect to toxicity and particle uptake were characterized using fluorescence microscopy and flow cytometry. This study demonstrated that ultra-small SLNs, as a nanoparticle delivery system, are suitable for intracellular targeting of different cell types.

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

In this study, a method for synthesizing ultra-small populations of biocompatible nanoparticles was described, as well as several in vitro methods by which to assess their cellular interactions.

Nanoparticle-based delivery vehicles have shown great promise for intracellular targeting applications, providing a mechanism to specifically alter ...

Identification of Metal Oxide Nanoparticles in Histological Samples by Enhanced Darkfield Microscopy and Hyperspectral Mapping

Nanomaterials are increasingly prevalent throughout industry, manufacturing, and biomedical research. The need for tools and techniques that aid in the identification, localization, and characterization of nanoscale materials in biological samples is on the rise. Currently available methods, such as electron microscopy, tend to be resource-intensive, making their use prohibitive for much of the research community. Enhanced darkfield microscopy complemented with a hyperspectral imaging system may provide a solution to this bottleneck by enabling rapid and less expensive characterization of nanoparticles in histological samples. This method allows for high-contrast nanoscale imaging as well as nanomaterial identification. For this technique, histological tissue samples are prepared as they would be for light-based microscopy. First, positive control samples are analyzed to generate the reference spectra that will enable the detection of a material of interest in the sample. Negative controls without the material of interest are also analyzed in order to improve specificity (reduce false positives). Samples can then be imaged and analyzed using methods and software for hyperspectral microscopy or matched against these reference spectra in order to provide maps of the location of materials of interest in a sample. The technique is particularly well-suited for materials with highly unique reflectance spectra, such as noble metals, but is also applicable to other materials, such as semi-metallic oxides. This technique provides information that is difficult to acquire from histological samples without the use of electron microscopy techniques, which may provide higher sensitivity and resolution, but are vastly more resource-intensive and time-consuming than light microscopy.

Enhanced darkfield microscopy and hyperspectral imaging with spectral mapping enable screening, localization, and identification of nanoscale materials in histological samples with improved speed and accuracy over traditional methods. The goal of this paper is to provide methods for darkfield imaging and hyperspectral mapping of metal oxide nanoparticles in histological samples.

Nanomaterials are increasingly prevalent throughout industry, manufacturing, and biomedical research. The need for tools and techniques that aid in the ...

Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis

A fast and reproducible microwave-driven protocol has been developed for the synthesis of neridronate-functionalized nanoparticles. Starting from the synthesis of hydrophobic nanoparticles, our method is based on an adaptation from thermal decomposition method to microwave driven synthesis. The new methodology produces a decrease in the reaction times in comparison with traditional procedures. Moreover, the use of the microwave technology increases the reproducibility of the reactions, something important from the point of view of clinical applications. The novelty of this iron oxide nanoparticle is the attachment of Neridronate. The use of this molecule leads a bisphosphonate moiety towards the outside of the nanoparticle that provides Ca2+ binding properties in vitro and selective accumulation in vivo in the atheroma plaque. The protocol allows the synthesis and plaque detection in about 3 hr since the initial synthesis from organic precursors. Their accumulation in the atherosclerotic area in less than 1 hr provides a contrast agent particularly suitable for clinical applications.

Microwave technology enables extremely fast synthesis of iron oxide nanoparticles for atherosclerosis plaque characterization. The use of an aminobisphosphonate in the external side of the nanoparticle provides a fast accumulation in the atherosclerotic area.

A fast and reproducible microwave-driven protocol has been developed for the synthesis of neridronate-functionalized nanoparticles. Starting from the ...

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Antibody-conjugates (ACs) modified with virus-derived peptides are a potentially powerful class of tumor cell delivery agents for molecular payloads used in cancer treatment and imaging due to increased cellular accumulation over current ACs. During early AC in vitro development, fluorescence techniques and radioimmunoassays are sufficient for determining intracellular localization, accumulation efficiency, and target cell specificity. Currently, there is no consensus on standardized methods for preparing cells for evaluating AC intracellular accumulation and localization. The initial testing of ACs modified with virus-derived peptides is critical especially if several candidates have been constructed. Determining intracellular accumulation by fluorescence can be affected by background signal from ACs at the cell surface and complicate the interpretation of accumulation. For radioimmunoassays, typically treated cells are fractionated and the radioactivity in different cell compartments measured. However, cell lysis varies from cell to cell and often nuclear and cytoplasmic compartments are not adequately isolated. This can produce misleading data on payload delivery properties. The intravenous injection of radiolabeled virus-derived peptide-modified ACs in tumor bearing mice followed by radionuclide imaging is a powerful method for determining tumor targeting and payload delivery properties at the in vivo phase of development. However, this is a relatively recent advancement and few groups have evaluated virus-derived peptide-modified ACs in this manner. We describe the processing of treated cells to more accurately evaluate virus-derived peptide-modified AC accumulation when using confocal microscopy and radioimmunoassays. Specifically, a method for trypsinizing cells to remove cell surface bound ACs. We also provide a method for improving cellular fractionation. Lastly, this protocol provides an in vivo method using positron emission tomography (PET) for evaluating initial tumor targeting properties in tumor-bearing mice. We use the radioisotope 64Cu (t1/2 = 12.7 h) as an example payload in this protocol.

Viral-derived peptides coupled to antibody-conjugates (ACs) is an approach gaining momentum due to the potential of delivering molecular payloads with increased tumor cell accumulation. Utilizing common methods to evaluate peptide conjugation, AC and payload intracellular accumulation, and tumor targeting, this protocol helps researchers during the key initial development phases.

Antibody-conjugates (ACs) modified with virus-derived peptides are a potentially powerful class of tumor cell delivery agents for molecular payloads used ...

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

While CD133+ hematopoietic stem cells (SCs) have been proven to provide high potential in the field of regenerative medicine, their low retention rates after injection into injured tissues as well as the observed massive cell death rates lead to very restricted therapeutic effects. To overcome these limitations, we sought to establish a non-viral based protocol for suitable cell engineering prior to their administration. The modification of human CD133+ expressing SCs using microRNA (miR) loaded magnetic polyplexes was addressed with respect to uptake efficiency and safety as well as the targeting potential of the cells. Relying on our protocol, we can achieve high miR uptake rates of 80&#8211;90% while the CD133+ stem cell properties remain unaffected. Moreover, these modified cells offer the option of magnetic targeting. We describe here a safe and highly efficient procedure for the modification of CD133+ SCs. We expect this approach to provide a standard technology for optimization of therapeutic stem cell effects and for monitoring of the administered cell product via magnetic resonance imaging (MRI).

This protocol illustrates a safe and efficient procedure to modify CD133+ hematopoietic stem cells. The presented non-viral, magnetic polyplex-based approach may provide a basis for the optimization of therapeutic stem cell effects as well as for monitoring the administered cell product via magnetic resonance imaging.

While CD133+ hematopoietic stem cells (SCs) have been proven to provide high potential in the field of regenerative medicine, their low retention rates ...

Catalytic Scavenging of Plant Reactive Oxygen Species In Vivo by Anionic Cerium Oxide Nanoparticles

Reactive oxygen species (ROS) accumulation is a hallmark of plant abiotic stress response. ROS play&#160;a dual role in plants by acting as signaling molecules at low levels and damaging molecules at high levels. Accumulation of ROS in stressed plants can damage metabolites, enzymes, lipids, and DNA, causing a reduction of plant growth and yield. The ability of cerium oxide nanoparticles (nanoceria) to catalytically scavenge ROS in vivo provides a unique tool to understand and bioengineer plant abiotic stress tolerance. Here, we present a protocol to synthesize and characterize poly (acrylic) acid coated nanoceria (PNC), interface the nanoparticles with plants via leaf lamina infiltration, and monitor their distribution and ROS scavenging in vivo using confocal microscopy. Current molecular tools for manipulating ROS accumulation in plants are limited to model species and require laborious transformation methods. This protocol for in vivo ROS scavenging has the potential to be applied to wild type plants with broad leaves and leaf structure like Arabidopsis thaliana.

Catalytic Scavenging of Plant Reactive Oxygen Species In Vivo by Anionic Cerium Oxide Nanoparticles

Here, we present a protocol for the synthesis and characterization of cerium oxide nanoparticles (nanoceria) for ROS (reactive oxygen species) scavenging in vivo, nanoceria imaging in plant tissues by confocal microscopy, and in vivo monitoring of nanoceria ROS scavenging by confocal microscopy.

Reactive oxygen species (ROS) accumulation is a hallmark of plant abiotic stress response. ROS play&#160;a dual role in plants by acting as signaling ...

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

The human Fibroblast Growth Factor Receptor (FGFR) family comprises four members, namely, FGFR1, FGFR2, FGFR3, and FGFR4, that are involved in various biological activities including cell proliferation, survival, migration and differentiation. Several aberrations in the FGFR signaling pathway, owing to mutations or gene amplification events, have been identified in various types of cancers. Hence, recent research has focused on developing strategies involving therapeutic targeting of FGFRs. Current FGFR inhibitors at various stages of pre-clinical and clinical development include either small molecule inhibitors of tyrosine kinases or monoclonal antibodies, with only a few peptide- based inhibitors in the pipeline. Here, we provide a protocol using phage display technology to screen small peptides as antagonists of FGFR2. Briefly, a library of phage-displayed peptides was incubated in a plate coated with FGFR2. Subsequently, unbound phage was washed off by TBST (TBS + 0.1% [v/v] Tween-20), and bound phage was eluted with 0.2 M glycine-HCl buffer (pH 2.2). The eluted phage was further amplified and used as input for the next round of biopanning. Following three rounds of biopanning, the peptide sequences of individual phage clones were identified by DNA sequencing. Finally, the screened peptides were synthesized and analyzed for affinity and biological activity.

Herein, we present a detailed protocol for screening small peptides that bind to FGFR2 using a phage display peptide library. We further analyze the affinity of the selected peptides toward FGFR2 in vitro and its ability to suppress cell proliferation.

The human Fibroblast Growth Factor Receptor (FGFR) family comprises four members, namely, FGFR1, FGFR2, FGFR3, and FGFR4, that are involved in various ...

Using Magnetometry to Monitor Cellular Incorporation and Subsequent Biodegradation of Chemically Synthetized Iron Oxide Nanoparticles

Magnetic nanoparticles, made of iron oxide, present a peculiar interest for a wide range of biomedical applications for which they are often internalized in cells and then left within. One challenge is to assess their fate in the intracellular environment with reliable and precise methodologies. Herein, we introduce the use of the vibrating sample magnetometer (VSM) to precisely quantify the integrity of magnetic nanoparticles within cells by measuring their magnetic moment. Stem cells are first labeled with two types of magnetic nanoparticles; the nanoparticles have the same core produced via a fast and efficient microwave-based nonaqueous sol gel synthesis and differ in their coating: the commonly used citric acid molecule is compared to polyacrylic acid. The formation of 3D cell-spheroids is then achieved via centrifugation and the magnetic moment of these spheroids is measured at different times with the VSM. The obtained moment is a direct fingerprint of the nanoparticles&#8217; integrity, with decreasing values indicative of a nanoparticle degradation. For both nanoparticles, the magnetic moment decreases over culture time revealing their biodegradation. A protective effect of the polyacrylic acid coating is also shown, when compared to citric acid.

Iron oxide nanoparticles are synthesized via a nonaqueous sol gel procedure and coated with anionic short molecules or polymer. The use of magnetometry for monitoring the incorporation and biotransformations of magnetic nanoparticles inside human stem cells is demonstrated using a vibrating sample magnetometer (VSM).

Magnetic nanoparticles, made of iron oxide, present a peculiar interest for a wide range of biomedical applications for which they are often internalized ...